
The Future
of Innovation
LYVA Labs is here to drive economic growth through innovation across Liverpool City Region.

Latest News
LYVA Labs backs Spotlight Pathology’s AI blood cancer diagnostics
LYVA Labs has invested £250k into Sci-Tech Daresbury-based Spotlight Pathology, as part of a £1.4m seed funding round alongside Liverpool Seed Fund managed by AXM Capital, Deepbridge Capital, River Capital, UKI2S and EHE Startup Factory. The investment will support the commercialisation of Spotlight’s AI tools for blood cancer diagnosis and create six new jobs in the Liverpool City Region.
LYVA Labs joins iiCON as a core consortium partner.
LYVA Labs is pleased to announce it has joined the Infection Innovation Consortium (iiCON) as a core consortium partner. iiCON is a world leading centre for infection innovation and R&D – working with industry, academics, and clinicians to save and improve lives around the world by supporting innovation and progressing the development of antimicrobial products and treatments.
LYVA Labs invests in Respiosa to advance next-generation treatment for sleep apnoea
Respiosa, a Liverpool City Region–based MedTech company developing an implant for obstructive sleep apnoea (OSA), has secured £125k investment from LYVA Labs as part of a £498k funding round alongside PXN’s PraeSeed Programme, NLC Health Ventures, and angel investors. The investment will support the company as it advances its next-generation device towards a pivotal study and commercialisation.
.png?width=1200&height=500&name=Email%20Newsletter%20content%20(3).png)
“By investing now to establish ourselves as a hotbed of innovation and new technology, we’ll be able to attract many more high-skilled, well-paid jobs and attract many, many more jobs, businesses and opportunities from around the world.”
Steve Rotheram, Metro Mayor
Our Partners






